Last CNY17.15 CNY
Change Today 0.00 / 0.00%
Volume 0.0
002581 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:05 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

zibo wanchang science & te-a (002581) Snapshot

Open
--
Previous Close
CNY17.15
Day High
--
Day Low
--
52 Week High
04/18/14 - CNY17.27
52 Week Low
07/30/13 - CNY10.20
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
CNY0.70
Shares Outstanding
140.8M
EX-Date
06/6/14
P/E TM
--
Dividend
CNY0.50
Dividend Yield
2.92%
Current Stock Chart for ZIBO WANCHANG SCIENCE & TE-A (002581)

Related News

No related news articles were found.

zibo wanchang science & te-a (002581) Related Businessweek News

No Related Businessweek News Found

zibo wanchang science & te-a (002581) Details

Zibo Wanchang Science & Technology Co., Ltd. engages in the research, development, manufacture, and marketing of chemical products in China. The company offers trimethyl orthoformate, an organic synthesis intermediate for use in dope, dye, flavor, and other industries; and triethyl orthoformate and ethyl formate that are used as acetic acid or nitrocellulose solvents primarily in food, alcohol, and daily essence and other productions. Zibo Wanchang Science & Technology Co., Ltd. exports its products to Japan, South Korea, India, Brazil, Canada, the United States, Europe, and other countries and regions. The company was founded in 2000 and is based in Zibo, China.

Founded in 2000

zibo wanchang science & te-a (002581) Top Compensated Officers

General Manager and Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

zibo wanchang science & te-a (002581) Key Developments

Zibo Wanchang Science & Technology Co., Ltd. to Report Q1, 2014 Results on Apr 19, 2014

Zibo Wanchang Science & Technology Co., Ltd. announced that they will report Q1, 2014 results on Apr 19, 2014

Zibo Wanchang Science & Technology Co., Ltd., Annual General Meeting, Apr 18, 2014

Zibo Wanchang Science & Technology Co., Ltd., Annual General Meeting, Apr 18, 2014., at 09:00 China Standard Time. Agenda: To discuss 2013 work report of the board of directors; to discuss 2013 work report of the supervisory committee; to discuss 2013 financial resolution report; to discuss 2013 profit distribution plan; to discuss the appointment of audit firm; to discuss 2013 annual report and its summary; to discuss 2013 remuneration appraisal plan for directors, supervisors; and to discuss amendments to the articles of association of the company.

Zibo Wanchang Science & Technology Proposes Cash Dividend for the Year 2013; Proposes Amendments to the Articles of Association

Zibo Wanchang Science & Technology announced that the company will propose a cash dividend of CNY 5.00000000 per 10 shares (tax included) for the year 2013, at its AGM to be held on April 18, 2014. The company also proposed amendments to the articles of association of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002581:CH CNY17.15 CNY 0.00

002581 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002581.
View Industry Companies
 

Industry Analysis

002581

Industry Average

Valuation 002581 Industry Range
Price/Earnings 26.2x
Price/Sales 7.3x
Price/Book 3.1x
Price/Cash Flow 26.2x
TEV/Sales 6.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIBO WANCHANG SCIENCE & TE-A, please visit www.wanchang.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.